
Biossil Exits Stealth With $70M to Rescue Failed Drugs
Toronto AI biotech Biossil exits stealth with $70M co-led by Founders Fund and OpenAI to acquire and rescue failed drug candidates using large language models, with several molecules already in clinical trials.










